Cardiac Science to renegotiate UK's HeartSine terms
This article was originally published in Clinica
Executive Summary
Cardiac Science is terminating its agreement to buy a UK-based R&D company, HeartSine, which is developing cardiac arrhythmia detection algorithms and new defibrillation waveforms. Irvine, California-based Cardiac Sciences is attempting to gain better terms from the privately-owned HeartSine and is to "renegotiate under terms more favourable to Cardiac Science".